Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 8st April 2024 Vol. No. 13 ; Issue No.624
Publications

1. Kumar A, Sonkusare L, Noronha V, Deodhar J, Rao A, Kumar S, Castellino R, Gattani S, Dhekale R, Krishnamurthy J, Mahajan S, Daptadar A, Ansari N, Vagal M, Gota V, Mahajan P, Nookala M, Chitre A, Banavali S, Prabhash K, Ramaswamy A. (2024) An analysis of psychological problems in older Indian patients with cancer. Journal of Geriatric Oncology.

Site of the Week

MobiDB is a valuable resource for researchers studying intrinsically disordered proteins (IDPs). This database provides comprehensive information, analysis, and tools related to IDPs, aiding in the understanding of their structure, function, and dynamics.

desktop Image
Interesting Reads

Zhang C, Wei W, Tu S, Liang B, Li C, Li Y, Luo W, Wu Y, Dai X, Wang Y, Zheng L, Hao L, Zhang C, Luo Z, Chen YG, Yan X. (2024) Upregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma. Journal of Biological Chemistry.

Video of the Week
Kinases-Challenging and Potential Target for New Age Cancer Therapeutics
Upcoming Events
EMBO Workshop: Nuclear Mechano-Genomics

April 16-19, 2024

At Sardinia, Italy.

Cell Symposia: Exercise Metabolism

May 5-7, 2024

At Altis Grand Hotel, Lisbon, Portugal

Innovations in Single Cell Omics

May 27-28, 2024

At Barcelona

Do You Know?

In 2018, James P. Allison and Tasuku Honjo won the Nobel Prize in Physiology or Medicine for their discovery of cancer therapy by inhibition of negative immune regulation.

back Image
Cancer News
Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types.

MedicalXpress, 27/03/2024

DNMT and EZH2 inhibitors work by controlling the epigenetic processes that regulate gene expression. In cancer, epigenetic errors enable malignant cells to survive and proliferate and offer critical targets for treatment...

Biocompatible nanoparticles modified with ATP can enhance systemic delivery of cancer immunotherapy.

Phys.org, 27/03/2024

Researchers validated their work using paclitaxel, a chemotherapy drug used to treat several types of cancers. They found that tumors grew slower in mice treated with paclitaxel enclosed within ATP-modified nanoparticles than in mice treated with paclitaxel in non-modified nanoparticles...

Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer.

ScienceDaily, 26/03/2024

A new study suggest that using CXCL9 and CXCL10-producing dendritic cells alongside immunotherapy can be a promising strategy to overcome treatment resistance and improve clinical outcomes for patients with non-small cell lung cancer...

2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)